BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 17898224)

  • 1. Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43.
    Zhang YJ; Xu YF; Dickey CA; Buratti E; Baralle F; Bailey R; Pickering-Brown S; Dickson D; Petrucelli L
    J Neurosci; 2007 Sep; 27(39):10530-4. PubMed ID: 17898224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity.
    Zhang YJ; Xu YF; Cook C; Gendron TF; Roettges P; Link CD; Lin WL; Tong J; Castanedes-Casey M; Ash P; Gass J; Rangachari V; Buratti E; Baralle F; Golde TE; Dickson DW; Petrucelli L
    Proc Natl Acad Sci U S A; 2009 May; 106(18):7607-12. PubMed ID: 19383787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fine structural analysis of the neuronal inclusions of frontotemporal lobar degeneration with TDP-43 proteinopathy.
    Thorpe JR; Tang H; Atherton J; Cairns NJ
    J Neural Transm (Vienna); 2008 Dec; 115(12):1661-71. PubMed ID: 18974920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of Progranulin Expression Leads to Formation of Intranuclear TDP-43 Inclusions In Vitro: A Cell Model of Frontotemporal Lobar Degeneration.
    Zhu J; Wang N; Li X; Zheng X; Zhao J; Xia H; Mao Q
    J Neuropathol Exp Neurol; 2019 Dec; 78(12):1124-1129. PubMed ID: 31626287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolytic processing of TAR DNA binding protein-43 by caspases produces C-terminal fragments with disease defining properties independent of progranulin.
    Dormann D; Capell A; Carlson AM; Shankaran SS; Rodde R; Neumann M; Kremmer E; Matsuwaki T; Yamanouchi K; Nishihara M; Haass C
    J Neurochem; 2009 Aug; 110(3):1082-94. PubMed ID: 19522733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspase-cleaved TAR DNA-binding protein-43 is a major pathological finding in Alzheimer's disease.
    Rohn TT
    Brain Res; 2008 Sep; 1228():189-98. PubMed ID: 18634762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Frontotemporal dementia (FTD) and genetic mutations including progranulin gene].
    Arai T; Hasegawa M; Nishihara M; Nonaka T; Kametani F; Yoshida M; Hashizume Y; Beach TG; Morita M; Nakano I; Oda T; Tsuchiya K; Akiyama H
    Rinsho Shinkeigaku; 2008 Nov; 48(11):990-3. PubMed ID: 19198141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetics of frontotemporal lobar degeneration.
    Rademakers R; Hutton M
    Curr Neurol Neurosci Rep; 2007 Sep; 7(5):434-42. PubMed ID: 17764635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Missense mutations in the progranulin gene linked to frontotemporal lobar degeneration with ubiquitin-immunoreactive inclusions reduce progranulin production and secretion.
    Shankaran SS; Capell A; Hruscha AT; Fellerer K; Neumann M; Schmid B; Haass C
    J Biol Chem; 2008 Jan; 283(3):1744-1753. PubMed ID: 17984093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies.
    Uryu K; Nakashima-Yasuda H; Forman MS; Kwong LK; Clark CM; Grossman M; Miller BL; Kretzschmar HA; Lee VM; Trojanowski JQ; Neumann M
    J Neuropathol Exp Neurol; 2008 Jun; 67(6):555-64. PubMed ID: 18520774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A morphometric study of the spatial patterns of TDP-43 immunoreactive neuronal inclusions in frontotemporal lobar degeneration (FTLD) with progranulin (GRN) mutation.
    Armstrong RA; Cairns NJ
    Histol Histopathol; 2011 Feb; 26(2):185-90. PubMed ID: 21154232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantitative study of the neuropathology of 32 sporadic and familial cases of frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP).
    Armstrong RA; Carter D; Cairns NJ
    Neuropathol Appl Neurobiol; 2012 Feb; 38(1):25-38. PubMed ID: 21696412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human genetics as a tool to identify progranulin regulators.
    Nicholson AM; Finch NA; Rademakers R
    J Mol Neurosci; 2011 Nov; 45(3):532-7. PubMed ID: 21626010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U.
    Tsai KJ; Yang CH; Fang YH; Cho KH; Chien WL; Wang WT; Wu TW; Lin CP; Fu WM; Shen CK
    J Exp Med; 2010 Aug; 207(8):1661-73. PubMed ID: 20660618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Igaz LM; Kwong LK; Xu Y; Truax AC; Uryu K; Neumann M; Clark CM; Elman LB; Miller BL; Grossman M; McCluskey LF; Trojanowski JQ; Lee VM
    Am J Pathol; 2008 Jul; 173(1):182-94. PubMed ID: 18535185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression analysis of frontotemporal lobar degeneration of the motor neuron disease type with ubiquitinated inclusions.
    Mishra M; Paunesku T; Woloschak GE; Siddique T; Zhu LJ; Lin S; Greco K; Bigio EH
    Acta Neuropathol; 2007 Jul; 114(1):81-94. PubMed ID: 17569064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations.
    Maekawa S; Leigh PN; King A; Jones E; Steele JC; Bodi I; Shaw CE; Hortobagyi T; Al-Sarraj S
    Neuropathology; 2009 Dec; 29(6):672-83. PubMed ID: 19496940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Arai T; Hasegawa M; Akiyama H; Ikeda K; Nonaka T; Mori H; Mann D; Tsuchiya K; Yoshida M; Hashizume Y; Oda T
    Biochem Biophys Res Commun; 2006 Dec; 351(3):602-11. PubMed ID: 17084815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain.
    Busch JI; Martinez-Lage M; Ashbridge E; Grossman M; Van Deerlin VM; Hu F; Lee VM; Trojanowski JQ; Chen-Plotkin AS
    Acta Neuropathol Commun; 2013 Jul; 1():36. PubMed ID: 24252750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontotemporal lobar degeneration with ubiquitin-positive, but TDP-43-negative inclusions.
    Josephs KA; Lin WL; Ahmed Z; Stroh DA; Graff-Radford NR; Dickson DW
    Acta Neuropathol; 2008 Aug; 116(2):159-67. PubMed ID: 18553091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.